These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22568629)

  • 1. Vascular strategies for enhancing tumour response to radiation therapy.
    El Kaffas A; Tran W; Czarnota GJ
    Technol Cancer Res Treat; 2012 Oct; 11(5):421-32. PubMed ID: 22568629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour vascular targeting.
    Neri D; Bicknell R
    Nat Rev Cancer; 2005 Jun; 5(6):436-46. PubMed ID: 15928674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiology and vascular targeting in glioma.
    Short SC; Harney J
    Curr Opin Neurol; 2003 Dec; 16(6):651-5. PubMed ID: 14624072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiogenesis inhibitors and radiotherapy].
    Riesterer O
    Praxis (Bern 1994); 2012 Aug; 101(16):1031-7. PubMed ID: 22878946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular damaging agents.
    Patterson DM; Rustin GJ
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):443-56. PubMed ID: 17459681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis and radiotherapy (vessels, anaemia, oxygen and radiosensitivity)].
    Lartigau E
    Bull Cancer; 2007 Jul; 94 Spec No():S197-202. PubMed ID: 17846005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of radiation therapy and antiangiogenic therapy.
    O'Reilly MS
    Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment.
    Pasquier E; André N; Braguer D
    Curr Cancer Drug Targets; 2007 Sep; 7(6):566-81. PubMed ID: 17896922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
    Wachsberger P; Burd R; Dicker AP
    Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
    van Kempen LC; Leenders WP
    Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
    Viallard C; Larrivée B
    Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular targeting therapy: potential benefit depends on tumor and host related effects.
    Horsman MR; Bohn AB; Busk M
    Exp Oncol; 2010 Sep; 32(3):143-8. PubMed ID: 21403608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tumor response to radiation and vascular targeting therapy in mice using quantitative ultrasound spectroscopy.
    El Kaffas A; Sadeghi-Naini A; Falou O; Tran WT; Zhou S; Hashim A; Fernandes J; Giles A; Czarnota GJ
    Med Phys; 2015 Aug; 42(8):4965-73. PubMed ID: 26233222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy.
    Mazeron R; Anderson B; Supiot S; Paris F; Deutsch E
    Cancer Treat Rev; 2011 Oct; 37(6):476-86. PubMed ID: 21546163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vascular perfusion as the origin of neoplasm resistance to radio- and chemotherapy].
    Martinive P; Coucke PA
    Rev Med Liege; 2010 Mar; 65(3):133-9. PubMed ID: 20411817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.
    Denekamp J
    Br J Radiol; 1993 Mar; 66(783):181-96. PubMed ID: 7682469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis and angiogenesis inhibitors in cancer.
    Giavazzi R; Taraboletti G
    Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy.
    Kim DW; Huamani J; Fu A; Hallahan DE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):38-46. PubMed ID: 16377414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis.
    Drevs J; Schneider V
    J Intern Med; 2006 Dec; 260(6):517-29. PubMed ID: 17116002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.